| Dalhousie University | |
|---|---|
| Logo placeholder | |
| Location | Halifax, Nova Scotia, Canada |
| Type | Public Research University |
| Website | https://www.dal.ca/ |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Biomarkers |
| Founded | 1863 |
Dalhousie University is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Dalhousie University is a public research university located in Halifax, Nova Scotia, Canada. Founded in 1863, Dalhousie is the oldest university in Atlantic Canada and has grown to become one of Canada's leading research institutions.[1] The university is named after George Ramsay, 9th Earl of Dalhousie, who served as Governor General of British North America.
Dalhousie is home to the Brain Repair Centre, a multidisciplinary research facility focused on understanding and treating neurological disorders. The centre brings together researchers from neuroscience, medicine, engineering, and psychology.[2]
Dalhousie's unique location provides access to marine resources for studying novel compounds with neuroprotective properties. Researchers investigate marine-derived compounds for potential therapeutic applications in neurodegenerative diseases.
Key research areas include:
Dalhousie researchers have access to advanced neuroimaging facilities, including:
| Disease | Research Focus |
|---|---|
| Alzheimer's Disease | Biomarkers, early detection, marine-derived therapeutics |
| Parkinson's Disease | Neuroinflammation, alpha-synuclein |
| Multiple Sclerosis | Demyelination, immune modulation |
| Stroke | Recovery mechanisms, neuroplasticity |
Dalhousie researchers have made significant contributions to biomarker discovery for neurodegenerative diseases. Dr. Sultan Darvesh's work on butyrylcholinesterase as a biomarker for Alzheimer's disease has provided new insights into early detection methods.[3]
The university's unique position in Atlantic Canada has enabled research into marine-derived compounds with neuroprotective properties. Studies on compounds from marine sponges and algae have shown promise in preclinical models of neurodegeneration.
Research teams at Dalhousie have developed novel neuroimaging techniques for early detection of neurodegenerative changes, particularly in Alzheimer's and Parkinson's diseases.
Dalhousie offers graduate training through:
The university maintains research partnerships with:
Dalhousie continues to invest in research infrastructure, including:
The study of Dalhousie University has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] "History of Dalhousie University." Dalhousie Archives. https://archives.dal.ca/
[2] "Brain Repair Centre." Dalhousie University. https://brainrepair.ca/
[3] Darvesh S, et al. "Butyrylcholinesterase as a biomarker for Alzheimer's disease." J Neurochem. 2020.
[4] "Marine Compounds in Neurodegeneration." Marine Drugs. 2021.
[5] "Neuroscience Research at Dalhousie." Faculty of Medicine. https://medicine.dal.ca/research